While reporting financial results for the second quarter on Wednesday, biopharmaceutical company Alkermes plc (ALKS) raised its earnings and revenue guidance for the full-year 2021, based on the strong first half performance and anticipated continued strength in the business.
from RTT - Earnings https://ift.tt/3l6A4Ur
via IFTTT
No comments:
Post a Comment